Applied DNA Sciences Inc (APDN)
3.63
-0.12
(-3.20%)
USD |
NASDAQ |
May 06, 16:00
3.63
0.00 (0.00%)
After-Hours: 16:39
Applied DNA Sciences SG&A Expense (Quarterly): 3.084M for Dec. 31, 2023
SG&A Expense (Quarterly) Chart
Historical SG&A Expense (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 3.084M |
September 30, 2023 | 3.311M |
June 30, 2023 | 3.292M |
March 31, 2023 | 3.523M |
December 31, 2022 | 2.625M |
September 30, 2022 | 3.756M |
June 30, 2022 | 3.033M |
March 31, 2022 | 3.573M |
December 31, 2021 | 4.736M |
September 30, 2021 | 3.496M |
June 30, 2021 | 2.884M |
March 31, 2021 | 3.091M |
December 31, 2020 | 3.310M |
September 30, 2020 | 2.783M |
June 30, 2020 | 2.589M |
March 31, 2020 | 2.286M |
December 31, 2019 | 2.373M |
September 30, 2019 | 2.260M |
June 30, 2019 | 2.407M |
March 31, 2019 | 2.529M |
December 31, 2018 | 3.082M |
September 30, 2018 | 3.572M |
June 30, 2018 | 2.882M |
March 31, 2018 | 1.997M |
December 31, 2017 | 2.593M |
Date | Value |
---|---|
September 30, 2017 | 2.790M |
June 30, 2017 | 3.403M |
March 31, 2017 | 3.230M |
December 31, 2016 | 3.901M |
September 30, 2016 | 2.623M |
June 30, 2016 | 2.577M |
March 31, 2016 | 2.523M |
December 31, 2015 | 3.169M |
September 30, 2015 | 3.086M |
June 30, 2015 | 3.223M |
March 31, 2015 | 2.901M |
December 31, 2014 | 4.672M |
September 30, 2014 | 3.156M |
June 30, 2014 | 2.948M |
March 31, 2014 | 3.298M |
December 31, 2013 | 3.846M |
September 30, 2013 | 2.682M |
June 30, 2013 | 3.241M |
March 31, 2013 | 2.754M |
December 31, 2012 | 2.521M |
September 30, 2012 | 1.886M |
June 30, 2012 | 1.752M |
March 31, 2012 | 1.825M |
December 31, 2011 | 2.152M |
September 30, 2011 | 3.860M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
2.260M
Minimum
Sep 2019
4.736M
Maximum
Dec 2021
3.074M
Average
3.084M
Median
Dec 2023
SG&A Expense (Quarterly) Benchmarks
Fonar Corp | 5.587M |
XWELL Inc | 6.392M |
ProPhase Labs Inc | 8.022M |
Veracyte Inc | 48.21M |
OncoCyte Corp | 2.391M |